Original Research
Accepted on 17 May 2024
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1415846
Volumes
1,221 Publications
Clinical Trial
Accepted on 17 May 2024
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a soluble guanylate cyclase stimulator, HEC95468, in healthy volunteers: a randomized, double-blinded, placebo-controlled phase 1 trial
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1359939
Systematic Review
Accepted on 17 May 2024
Concomitant use of renin-angiotensin system inhibitors augments the efficacy of immune checkpoint inhibitors: A systematic review and metaanalysis
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1378577
Original Research
Accepted on 17 May 2024
Implementation of Risk-based Lipid-lowering Therapies in Older (age ≥ 65 years) and Very-old Adults (age ≥ 75 years) with Ischemic Heart Disease in the Greater Salzburg Region
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1357334
Original Research
Accepted on 17 May 2024
Clinical significance and biological function of interferon regulatory factor 1 in non-small cell lung cancer
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413699
Review
Accepted on 17 May 2024
Gut-directed therapy in Parkinson's disease
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1407925
Original Research
Accepted on 17 May 2024
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1403093
Editorial
Published on 17 May 2024
Editorial: Anti-inflammatory drug development focusing on immune mediated diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413141
Systematic Review
Published on 17 May 2024
Efficacy and safety of FLT3 inhibitors in monotherapy of hematological and solid malignancies: a systemic analysis of clinical trials
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1294668
Original Research
Published on 17 May 2024
Benserazide, a cystathionine beta-synthase (CBS) inhibitor, potentially enhances the anticancer effects of paclitaxel via inhibiting the S-sulfhydration of SIRT1 and the HIF1-α/VEGF pathway
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1404532
- 103 views
Correction
Published on 17 May 2024
Corrigendum: NmFGF1-regulated glucolipid metabolism and angiogenesis improves functional recovery in a mouse model of diabetic stroke and acts via the AMPK signaling pathway
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1392148
Original Research
Published on 17 May 2024
To elucidate the mechanism of “Scrophulariae Radix–Fritillaria” in goiter by integrated metabolomics and serum pharmaco-chemistry
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1206718
Original Research
Published on 17 May 2024
Repeated epidural delivery of Shinbaro2: effects on neural recovery, inflammation, and pain modulation in a rat model of lumbar spinal stenosis
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1324251
Clinical Trial
Published on 17 May 2024
A single-dose, randomized, open-label, four-period, crossover equivalence trial comparing the clinical similarity of the proposed biosimilar rupatadine fumarate to reference Wystamm® in healthy Chinese subjects
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1328142
Original Research
Published on 17 May 2024
LP340, a novel histone deacetylase inhibitor, decreases liver injury and fibrosis in mice: role of oxidative stress and microRNA-23a
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1386238
- 129 views
Review
Published on 17 May 2024
The structure and function of FUN14 domain-containing protein 1 and its contribution to cardioprotection by mediating mitophagy
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389953
- 218 views